Primary tabs

Equine obesity is increasingly being recognised as a globally important welfare issue due to a variety of associated adverse consequences including orthopaedic disease, hyperlipaemia, hyperthermia, infertility and poor performance but perhaps most importantly laminitis. It was only in the 1980s that the potential link between obesity and insulin resistance was recognised and suggested as an alternative explanation for why certain individuals appeared more susceptible to laminitis, rather than excessive adiposity alone.  

What will I gain from watching this webinar?

This webinar will discuss how definitions and terminology have evolved, including the change in emphasis from insulin resistance to insulin dysregulation when discussing endocrinopathic or hyper-insulinemic laminitis risk. It will also discuss how our understanding of the Equine Metabolic Syndrome (EMS) has changed over time with insulin dysregulation rather than obesity now being accepted as the most consistent characteristic of EMS. It will outline how dietary and gut-related factors may not only promote hyperinsulinaemia but may also be used in the diagnosis and most importantly the management of insulin dysregulation. In addition, the important role of exercise in the management of both obesity and insulin dysregulation will be discussed.

Continuing Professional Development (CPD)

This webinar has been endorsed by the Association for Nutrition (AfN) (EN175).

Share